Somatic POLE Mutation and Ultra-Hypermutated Genotype in a De Novo High-Grade, Isocitrate Dehydrogenase Wild-Type Glioma: Treatment Implications.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38237101.
- Also identified by DOI 10.1200/PO.23.00324.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pembrolizumab leads to a durable response in ultra-hypermutated, high-grade, glioma.
Medical subject headings
- Brain Neoplasms
- Glioma